We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Cladribine, Cytarabine and Idarubicin in Patients With Relapsed Acute Myelocytic Leukemia (AML)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00126321
Recruitment Status : Unknown
Verified February 2010 by University Hospital, Bonn.
Recruitment status was:  Recruiting
First Posted : August 3, 2005
Last Update Posted : February 2, 2010
Information provided by:
University Hospital, Bonn

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : November 2010
  Estimated Study Completion Date : March 2011